Regeneron Pharma(REGN.US)

Last Updated 19:00:00 ET
longbridge loading

Pre-market trend | Regeneron Pharma (REGN) plummeted nearly 10% on May 18, is short interest accelerating?

Technical Forecast·
US
REGN
-0.28%
US
IXJ
+0.67%
US
BBH
-0.36%
Technical Forecast·
US
REGN
-0.28%
US
IXJ
+0.67%
US
BBH
-0.36%

Regeneron signs $2.32bn deal with Parabilis for Helicon conjugates

Pharmaceutical Technology·
US
REGN
-0.28%
Pharmaceutical Technology·
US
REGN
-0.28%

18:24 ETRegeneron Pharmaceuticals Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Regeneron Pharmaceuticals (REGN)

prnewswire·
US
REGN
-0.28%
US
ARKG
-1.46%
US
VHT
+0.63%
prnewswire·
US
REGN
-0.28%
US
ARKG
-1.46%
US
VHT
+0.63%

Health Care Up on Rotation Into Lagging Sectors — Health Care Roundup

MorningStar·
US
REGN
-0.28%
US
PBE
-0.24%
US
XLV
+0.81%
MorningStar·
US
REGN
-0.28%
US
PBE
-0.24%
US
XLV
+0.81%

Equity Markets Mixed as Trump Aborts Plan to Attack Iran

fidelity·
US
D
-0.62%
US
NVDL
-2.50%
US
NVDX
-2.62%
fidelity·
US
D
-0.62%
US
NVDL
-2.50%
US
NVDX
-2.62%

Regeneron Sinks 10% on Failed Phase 3 Melanoma Trial. What Comes Next for REGN Stock.

Barchart Option·
US
REGN
-0.28%
Barchart Option·
US
REGN
-0.28%
© 2026 Longbridge｜Disclaimer